CathWorks
Noninvasive FFR Measurements for Coronary Interventions
Startup D Health Tech & Life Sciences Est. 2013
Total Raised
$151.79M
D
Last Round
$75M
5 rounds
Investors
9
9 public
Team
6
51-200 employees
Confidence
100/100
News
21
articles
Patents
1
About
CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize coronary artery disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective, FFR-based decision-making tool for physicians. The companys current focus is specifically on bringing the CathWorks FFRangio System to market in order to provide quick, precise, and objective intraprocedural FFR guidance that will be practical for every case. CathWorks FFRangio System carries the CE mark and received FDA 510(k) clearance in December 2018.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Core Technology
Artificial Intelligence
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
decision-makingdigital-healthcare3d-technologymedical-technologiesimagingheart-diseasesnon-invasivediagnosticscardiovascularmedical-devicescardiologydeep-learningdecision-supportpatients3d-imagingartificial-intelligencehealthcarehealthcare-providersalgorithmsx-raycomputer-visionhealthcare-itmedical-productsimage-processingsaasdeep-neural-networksmedical-equipment
Funding & Events
Oct 2017
B Round $15.8M
Triventures (Lead), Corundum Open Innovation, Planven Entrepreneur Ventures, Pontifax, BioStar Capital, Quark Venture
May 2019
Non-equity $994K
Israel Innovation Authority
Jul 2022
Undisclosed Round $75M
Medtronic (Lead)
Jan 2021
D Round $30M
Undisclosed Investor(s)
Feb 2019
C Round $30M
Deerfield Management (Lead)
News (21)
Jun 28, 2023 · www.prnewswire.com
growth-positive
CathWorks Announces First Patient Enrolled in Global ALL-RISE Study
CustomersPartners
Mar 23, 2023 · www.calcalistech.com
growth-positive
Israeli startup is aiming to transform how cardiovascular disease is diagnosed and treated | CTech
PartnersCustomers
Oct 6, 2022 · www.prnewswire.com
growth-positive
Fourth Generation CathWorks FFRangio® System Receives Regulatory Approval in Japan
Customers
Jul 12, 2022 · www.prnewswire.com
growth-positive
Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition
Partners
Apr 6, 2022 · www.prnewswire.com
growth-positive
CathWorks and Quest International Announce Global Post-Sales Technical Service Support Partnership
Partners
Mar 31, 2022 · www.prnewswire.com
growth-positive
CathWorks Presents New Data and Latest Innovations at ACC 2022
CustomersPartners
Jun 14, 2021 · www.prnewswire.com
growth-positive
CathWorks Announces Appointment of Ramin Mousavi as Chief Executive Officer and Board Member
Management Changes
Jan 10, 2021 · en.globes.co.il
growth-positive
Israeli angiography co CathWorks raises $30m
Investment
Dec 16, 2019 · www.mddionline.com
Can 3D Modeling Replace a Guidewire-Based Cardiac Procedure?
Dec 11, 2019 · www.prnewswire.com
growth-positive
CathWorks FFRangio™ System Receives Regulatory Approval in Japan
Customers
Jun 17, 2019 · en.globes.co.il
growth-positive
Medtronic signs marketing agreement with CathWorks
Partners
Mar 4, 2019 · venturebeat.com
growth-positive
CathWorks Appoints Chief Financial Officer
Management Changes
Feb 25, 2019 · venturebeat.com
growth-positive
CathWorks Adds Vice President of Global Marketing to Leadership Team
Management Changes
Feb 4, 2019 · venturebeat.com
growth-positive
CathWorks Announces Completion of $30 Million Financing
Investment
Dec 27, 2018 · venturebeat.com
growth-positive
CathWorks Names Paul Kapsner as Vice-President of Sales
Management Changes
Dec 20, 2018 · venturebeat.com
growth-positive
CathWorks FFRangio™ System Receives U.S. FDA Clearance
Customers
Sep 24, 2018 · venturebeat.com
growth-positive
CathWorks FFRangio™ Trial Meets Primary Endpoint and Exceeds Performance Goals
Customers
Aug 22, 2018 · venturebeat.com
growth-positive
CathWorks FFRangio™ System Files FDA 510(k) Submission
Investment
Oct 30, 2017 · www.mpo-mag.com
growth-positive
CathWorks Appoints New CEO
Management Changes
Oct 24, 2017 · www.prnewswire.com
growth-positive
CathWorks Announces FAST-FFR Pivotal Clinical Trial
Investment
+ 1 more articles
Details
Product Stage
Released
Employees
51-200
Exact Count
82
District
Center District
Founded
2013
Registrar
514882836
Crunchbase
cathworks
Locations
Rapaport Street 3, Kfar Saba, Israel
Jr Shinjuku Mirainatower, 4-chōme-1-6 Shinjuku, Shinjuku City, Tokyo 160-0022, Japan
4000 MacArthur Blvd, Newport Beach, CA 92660, USA
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Mar 27, 2025
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
markets
Team (6)
Ramin Mousavi
CEO
Ifat Lavi
Co-founder (No longer with the company)
Founder
Guy Lavi
Co-founder (No longer with the company)
Founder
Mica Mor Ben-David
Chief of Staff & Finance
Dalit Cohen Shipperman
VP HR
Asaf Jazcilevich
VP R&D
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2016-06-03T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)